Nabi Biopharmaceuticals
Records under this name other than patents Nabi Biopharmaceuticals holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Nabi Biopharmaceuticals
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,449,189 | Glycoconjugate vaccines for use in immune-compromised populations Formerly held Term ended Term ended Sep 21, 2022 · USPTO record | Term ended | Term ended Sep 21, 2022 | USPTO record |
| US 6,875,445 | Encapsulated Calcium Acetate Caplet and a Method for Inhibiting Gastrointestinal Phosphorous Absorption Formerly held Term ended Term ended Aug 19, 2021 · High confidence | Term ended | Term ended Aug 19, 2021 | High confidence |
| US 6,576,665 | Encapsulated Calcium Acetate Caplet and Amethod for Inhibiting Gastrointestinal Phosphorous Absorption Formerly held Term ended Term ended Jul 30, 2021 · High confidence | Term ended | Term ended Jul 30, 2021 | High confidence |
| US 6,355,625 | Compositions of &bgr;-glucans and specific IGIV Formerly held Term ended Term ended Sep 14, 2019 · USPTO record | Term ended | Term ended Sep 14, 2019 | USPTO record |
| US 7,030,101 | Compositions of Beta-Glucans and Specific Antibodies Formerly held Term ended Ended no later than Sep 14, 2019 · Low confidence | Term ended | Ended no later than Sep 14, 2019 | Low confidence |
| US 6,294,177 | Staphylococcus aureus antigen-containing whole cell vaccine Formerly held Term ended Term ended May 10, 2019 · USPTO record | Term ended | Term ended May 10, 2019 | USPTO record |
| US 7,754,225 | Method of protecting against staphylococcal infection Formerly held Lapsed on the fee record Ended Jul 13, 2018 · USPTO record | Lapsed on the fee record | Ended Jul 13, 2018 | USPTO record |
| US 6,194,161 | Staphylococcus aureus antigen Formerly held Term ended Term ended Jun 22, 2018 · USPTO record | Term ended | Term ended Jun 22, 2018 | USPTO record |
| US 6,936,258 | Staphylococcus antigen and vaccine Formerly held Lapsed on the fee record Ended Aug 30, 2017 · USPTO record | Lapsed on the fee record | Ended Aug 30, 2017 | USPTO record |
| US 7,531,633 | Staphylococcus antibodies Formerly held Lapsed on the fee record Ended May 12, 2017 · USPTO record | Lapsed on the fee record | Ended May 12, 2017 | USPTO record |